Urges Shareholders to Vote FOR NHI's Director Nominees on the WHITE Proxy CardStrongly Disagrees with ISS' Recommendation; Believes that it Would Put at Risk Company's Superior Shareholder Returns ...

Receives U.S. Patent for Groundbreaking Treatment for Opioid Use DisorderClinical Trial on Novel Analgesic, PF614-MPAR, Demonstrates Overdose Protection SAN DIEGO, CA / ACCESS Newswire / May 13, 2025 ...

FDA Clearance of Catamaran® SI Joint Fusion System for New Indication to Augment Spinal Fusion ~~ Catamaran® SI Joint Fusion Technology Protected with Robust Patent Portfolio of Twelve U.S. and ...

Record Revenue Highlighted by 70% Growth in Single-Use Navigation and Therapy Products SOLANA BEACH, CALIFORNIA / ACCESS Newswire / May 13, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), ...

Malini Saba partakes in a brand new article discussing her journey and success. RENO, NV / ACCESS Newswire / May 13, 2025 / Dr. Malini Saba, a globally respected entrepreneur, psychologist, and ...

The innovative GeneSwift reagent kit from Gator Bio, along with GFP, CMV, and SV40 reagents, are designed to maintain the ...

Surgeon-Turned-Philanthropist Calls for Action in Supporting Underserved Communities Worldwide ORANGE COUNTY, CA / ACCESS Newswire / May 13, 2025 / In a recent feature interview titled "Dr. Harrell E.

LOS ANGELES, CALIFORNIA / ACCESS Newswire / May 12, 2025 / Beauty-Stem Biomedical, a biotech-driven beauty and wellness ...

New Investment Accelerates CERTIFY Health's Mission to Revolutionize Patient Engagement and Streamline Healthcare Operations GAITHERSBURG, MD / ACCESS Newswire / May 13, 2025 / CERTIFY Health, a ...

LINCOLN, NEBRASKA / ACCESS Newswire / May 13, 2025 / Neighborhood LTC Pharmacy, a leader in pharmacy services for individuals with Intellectual and Developmental Disabilities (IDD), is thrilled to ...

HOUSTON, TX / ACCESS Newswire / May 13, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for ...

Promising results from the first-in-human study demonstrated that, at three-years post implantation, VenoValve remained safe and effective--achieving a high rate of patency, restoring deep venous ...